Mucocutaneous telangiectases of the head and neck in individuals with hereditary hemorrhagic telangiectasia - Analysis of distribution and symptoms

European Journal of Dermatology

Volumn 14, Issue 6, 2004, Pages 407-411

  Folz, Benedikt J ^a   Lippert, Burkard M ^a   Wollstein, Ana Cerra ^a   Tennie, Julia ^a   Happle, Rudolf ^a   Werner, Jochen A ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Distribution of telangiectases; Epistaxis; Hemorrhages; Hereditary hemorrhagic telangiectasia; Rendu Osler Weber; Vascular malformations

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FINGER; GENETIC DISORDER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MUCOCUTANEOUS TELANGIECTASIA; NEWBORN; NOSE MUCOSA; RENDU OSLER WEBER DISEASE; REVIEW; TELANGIECTASIA; TONGUE; VASCULAR LESION; VIDEORECORDING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HEAD; HUMANS; MALE; MIDDLE AGED; NECK; SEVERITY OF ILLNESS INDEX; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 9244263077     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene of hereditary hemorrhagic telangiectasia type 1. Nat Genet 1994; 8: 345-51.
2. Johnson DW, Berg JN, Baldwin MA, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary hemorrhagic telangiectasia type 2. Nat Genet 1996; 13: 189-95.
3. Gallione CJ, Repetto GM, Legius E, et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004; 303: 852-9.
4. Pau H, Corney AS, Murty GE. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): otorhinolaryngological manifestations. Clin Otolaryngol 2001; 20: 93-8.
5. Römer W, Burk M, Schneider W. Hereditäre hämorrhagische Teleangiektasie (Morbus Osler). Dtsch Med Wochenschr 1992; 117: 669-75.
6. Begbie ME, Wallace GM, Shovlin CL. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J 2003; 79: 18-24.
7. Plauchu H, de Chadarevian P, Bideau A, Robert M. Age-related clinical profile of hereditary hemorrhagic felangiectasia in an epidemiologically recruited population. Am J Med Genet 1989; 32: 291-7.
8. Folz BJ, Cerra Wollstein A, Alike H, et al. The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: A diagnostic study. Eur Arch Otorhinolaryngol 2003 Dec 1 7[Epub ahead of print].
9. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000; 91: 66-7.
10. Kress O, Cerra Wollstein A, Wagner HJ, Folz BJ, Werner JA, Alfke H. Embolisation pulmonaler arteriovenöser Malformationen bei hereditärer hämorrhagischer Teleangiektasie mittels elektrolytisch ablösbarer Spiralen. RöFo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr. Submitted for publication
11. Haitjema T, Westermann CJ, Overtoom TT, et al. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment. Arch Intern Med 1990; 156: 714-9.
12. Jacobson BS. Hereditary hemorrhagic telangiectasia: A model for blood vessel growth and enlargement. Am J Pathol 2000; 150: 737-42.
13. Fingerland A, Janoušek. Zur Histologie der Oslerschen Krankheit (Teleangiectasia hereditaria haemorrhagica). Arch Dermatol (Berlin) 1939; 178: 54-04.
14. Werner JA, Lippert BM, Geisthoff UW, Rudert H. Nd:YAG-Lasertherapie der rezidivierenden Epistaxis bei hereditärer hämorhagischer Telangiektasie. Laryngorhinootologie 1997; 70: 495-501.
15. Werner JA. Behondlungskonzept der rezidivierenden Epistaxis bei Patienten mit hereditärer hämorrhagischer Teleangiektasie. HNO 1999; 47: 525-7.
16. Folz BJ, Cerra Wollstein A, Werner JA. Multimodole Therapie der rezidivierenden Epistaxis bei M. Osler. Laryngorhinootologie 2003; 82: S860.
17. Bean WB. Notes on the natural history of vascular spiders in healthy persons. Arch Intern Med 1960; 106: 35-8.
18. McNicholl F, McMullin MF, Nevin NC, McMillan C. Hereditary benign telangiectasia - first family in Northern Ireland. Ulster Med J 1999; 68: 106-7.
19. Poblete-Gutiérrez P, Rübben A, Merk HF, Frank J. Unilateral facial telangiectases suggest type 1 segmental manifestation of OslerRendu-Weber syndrome in an 11-year-old boy. Eur J Dermatol 2003; 13: 537-9.
20. Happle R. Mosaicism in human skin: Understanding the patterns and mechanisms. Arch Dermatol 1993; 129: 1400-70.
21. Guttmacher AE, Marchuck DA, White Jr RI. Hereditary haemorrhagic telangiectasia. N Engl J Med 1995; 333: 918-24.
22. Lyans GD, Owens RE, Mouney DF. Argan laser destruction of cutaneous telangiectatic lesions. Laryngoscope 1981; 91: 1322-5.
23. Michel JL. Treatment of hemangiomas with 595 nm pulsed dye laser dermobeam. Eur J Dermatol 2003; 13: 130-41.